Medtronic Return on Investment 2010-2024 | MDT
Current and historical return on investment (ROI) values for Medtronic (MDT) over the last 10 years.
| Medtronic ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-07-31 | $5.16B | $74.47B | 6.87% |
| 2024-04-30 | $5.15B | $74.35B | 6.82% |
| 2024-01-31 | $5.66B | $76.15B | 7.46% |
| 2023-10-31 | $5.57B | $75.39B | 7.40% |
| 2023-07-31 | $5.63B | $75.83B | 7.54% |
| 2023-04-30 | $5.49B | $76.01B | 7.49% |
| 2023-01-31 | $5.59B | $73.83B | 7.71% |
| 2022-10-31 | $5.86B | $72.81B | 7.99% |
| 2022-07-31 | $6.02B | $70.32B | 8.07% |
| 2022-04-30 | $5.75B | $73.09B | 7.53% |
| 2022-01-31 | $5.69B | $77.00B | 7.33% |
| 2021-10-31 | $5.30B | $77.77B | 6.83% |
| 2021-07-31 | $4.67B | $77.62B | 6.04% |
| 2021-04-30 | $4.48B | $77.98B | 5.88% |
| 2021-01-31 | $3.20B | $77.43B | 4.26% |
| 2020-10-31 | $3.56B | $76.28B | 4.76% |
| 2020-07-31 | $3.98B | $73.31B | 5.33% |
| 2020-04-30 | $4.79B | $72.89B | 6.38% |
| 2020-01-31 | $6.42B | $76.69B | 8.50% |
| 2019-10-31 | $6.32B | $75.47B | 8.46% |
| 2019-07-31 | $6.52B | $75.30B | 8.78% |
| 2019-04-30 | $6.27B | $74.70B | 8.48% |
| 2019-01-31 | $6.25B | $73.62B | 8.46% |
| 2018-10-31 | $6.14B | $73.39B | 8.24% |
| 2018-07-31 | $6.49B | $74.01B | 8.59% |
| 2018-04-30 | $6.64B | $74.52B | 8.71% |
| 2018-01-31 | $6.40B | $76.26B | 8.34% |
| 2017-10-31 | $6.11B | $77.52B | 7.98% |
| 2017-07-31 | $5.60B | $76.74B | 7.28% |
| 2017-04-30 | $5.38B | $76.25B | 6.90% |
| 2017-01-31 | $5.27B | $75.42B | 6.64% |
| 2016-10-31 | $5.48B | $79.30B | 6.71% |
| 2016-07-31 | $5.40B | $81.02B | 6.47% |
| 2016-04-30 | $5.36B | $82.17B | 6.32% |
| 2016-01-31 | $3.95B | $84.50B | 4.59% |
| 2015-10-31 | $3.87B | $85.96B | 5.05% |
| 2015-07-31 | $3.76B | $86.52B | 6.03% |
| 2015-04-30 | $3.77B | $86.98B | 7.82% |
| 2015-01-31 | $3.91B | $46.81B | 11.57% |
| 2014-10-31 | $3.66B | $29.15B | 12.47% |
| 2014-07-31 | $3.68B | $29.57B | 12.60% |
| 2014-04-30 | $3.81B | $29.76B | 13.23% |
| 2014-01-31 | $4.70B | $28.96B | 16.50% |
| 2013-10-31 | $4.89B | $28.38B | 17.77% |
| 2013-07-31 | $4.87B | $28.16B | 18.34% |
| 2013-04-30 | $4.76B | $28.41B | 18.51% |
| 2013-01-31 | $4.78B | $25.15B | 19.35% |
| 2012-10-31 | $4.71B | $24.53B | 19.03% |
| 2012-07-31 | $4.75B | $24.64B | 19.09% |
| 2012-04-30 | $4.75B | $24.47B | 19.11% |
| 2012-01-31 | $4.52B | $25.42B | 18.24% |
| 2011-10-31 | $4.51B | $24.96B | 18.78% |
| 2011-07-31 | $4.38B | $24.54B | 18.82% |
| 2011-04-30 | $4.30B | $24.08B | 19.06% |
| 2011-01-31 | $4.37B | $22.44B | 19.94% |
| 2010-10-31 | $4.49B | $21.97B | 21.00% |
| 2010-07-31 | $4.63B | $21.68B | 22.15% |
| 2010-04-30 | $4.71B | $21.57B | 23.19% |
| 2010-01-31 | $4.32B | $20.32B | 21.81% |
| 2009-10-31 | $4.03B | $19.98B | 20.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $114.552B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
| Stryker (SYK) | United States | $137.290B | 32.08 |
| Boston Scientific (BSX) | United States | $122.743B | 37.38 |
| EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
| ResMed (RMD) | United States | $35.117B | 30.92 |
| Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
| Terumo (TRUMY) | Japan | $28.517B | 40.27 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
| Baxter (BAX) | United States | $19.851B | 13.46 |
| Insulet (PODD) | United States | $16.269B | 68.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
| Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
| ICU Medical (ICUI) | United States | $4.261B | 40.67 |
| Haemonetics (HAE) | United States | $4.084B | 20.20 |
| TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
| Neogen (NEOG) | United States | $3.599B | 37.75 |
| Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
| GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
| Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
| Envista Holdings (NVST) | United States | $3.398B | 18.13 |
| QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
| Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
| Warby Parker (WRBY) | United States | $1.614B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
| InMode (INMD) | Israel | $1.464B | 9.32 |
| AtriCure (ATRC) | United States | $1.372B | 0.00 |
| Owens & Minor (OMI) | United States | $1.247B | 9.63 |
| Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
| Evolus (EOLS) | United States | $1.006B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
| National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.64 |
| Quanterix (QTRX) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
| Jin Medical (ZJYL) | China | $0.439B | 0.00 |
| ZimVie (ZIMV) | United States | $0.435B | 40.41 |
| Valneva SE (VALN) | France | $0.432B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
| Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
| Biote (BTMD) | United States | $0.307B | 14.18 |
| Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Zynex (ZYXI) | United States | $0.257B | 45.00 |
| Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.163B | 67.33 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
| Brainsway (BWAY) | Israel | $0.135B | 161.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 11.44 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
| InterCure (INCR) | Israel | $0.087B | 14.62 |
| Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |